Navigation Links
Novo Nordisk's Victoza(R) Receives FDA Approval for Adults With Type 2 Diabetes
Date:1/25/2010

diabetes mellitus or diabetic ketoacidosis. It has not been studied in combination with insulin.    

About Victoza

Victoza is the first and only human GLP-1 analog with 97% homology to natural GLP-1. Like natural GLP-1, Victoza works by stimulating the beta cells to release insulin only when blood glucose levels are high. Due to this glucose-dependent mechanism of action, Victoza is associated with a low rate of hypoglycemia. The mechanism of blood glucose lowering also involves a delay in gastric emptying.

In clinical studies submitted for FDA review, Victoza's® safety and efficacy were evaluated in five trials, one of 52-weeks duration and four of 26-weeks duration.  These multinational trials evaluated Victoza in monotherapy as well as in combination with one or two oral anti-diabetic medications and showed better lowering of blood glucose than active comparators such as sulfonylureas and thiazolidinediones.  A1C reductions for Victoza 1.8 mg, in combination or as monotherapy, ranged from 1.0% to 1.5% across the five clinical studies with baselines ranging from 8.2% to 8.6%.  Victoza 1.8 mg + metformin reduced A1C by 1.0% and reduced weight by 6.2lbs.  The most common adverse reactions reported in patients treated with Victoza are headache, nausea, diarrhea, and anti-liraglutide antibody formation.  Immunogenicity-related events, including urticaria, were more common among Victoza-treated patients than among comparator-treated patients in clinical trials.

For full prescribing information, please go to Victoza.com or call 1-877-4VICTOZA (484-2869).

Conference call

On January 26, 2010 at 08:00 am CET, corresponding to 02:00 am EST, a conference call for investors will be held. Investors will be able to listen in via a link on the investor
'/>"/>

SOURCE Novo Nordisk
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
2. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
3. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
4. Abbott Receives Supplemental FDA Approval for its Best-in-Class in Sensitivity RealTime HIV-1 Viral Load Test
5. GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSKs Candidate Pre-pandemic Flu Vaccine to Start.
6. CryoCor Receives FDA Approval for Right Atrial Flutter
7. Ranbaxy Receives Approval to Manufacture and Market Hydrocodone Bitartrate and Acetaminophen Tablets USP
8. Dimericine(R) Receives FDA Fast Track Designation for Treatment Of Photosensitivity in XP Patients
9. Poniard Pharmaceuticals Receives FDA Fast Track Designation for Picoplatin for Treatment of Small Cell Lung Cancer
10. Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma
11. The Female Health Company Receives USAID DELIVER PROJECT Order for 5 Million Units
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... 31, 2014  Zacks.com announces the list of stocks featured ... analysts discuss the latest news and events impacting stocks and ... Biogen (Nasdaq: BIIB - Free Report ), Gilead (Nasdaq: ... PBYI - Free Report ), AbbVie (NYSE: ABBV - ... Report ). Today, Zacks is promoting its ,Buy, ...
(Date:7/31/2014)... and LONDON , July 31, 2014 ... and services provider for the medical industries, announced today the incorporation ... The United Kingdom has one of the ... USD 8.9 billion in 2012 and it is projected to increase ... at USD 234 billion in 2012, equal to 9.5% of GDP. ...
(Date:7/31/2014)... -- For the first time, cardiac surgeons, medical professionals ... SynCardia temporary Total Artificial Heart in a peer reviewed ... Journal of Visualized Experiments website. ... SynCardia Total Artificial Heart implantation   goo.gl/2OZyKW ... SynCardia Total Artificial Heart," a July 18, 2014 paper ...
Breaking Medicine Technology:The Zacks Analyst Blog Highlights: Biogen, Gilead, Puma Biotechnology, AbbVie and Celgene 2The Zacks Analyst Blog Highlights: Biogen, Gilead, Puma Biotechnology, AbbVie and Celgene 3The Zacks Analyst Blog Highlights: Biogen, Gilead, Puma Biotechnology, AbbVie and Celgene 4The Zacks Analyst Blog Highlights: Biogen, Gilead, Puma Biotechnology, AbbVie and Celgene 5The Zacks Analyst Blog Highlights: Biogen, Gilead, Puma Biotechnology, AbbVie and Celgene 6genae Opens Offices in London 2How to Implant the SynCardia Total Artificial Heart Detailed in Peer Reviewed Paper and Matching Video 2How to Implant the SynCardia Total Artificial Heart Detailed in Peer Reviewed Paper and Matching Video 3
(Date:7/31/2014)... INDIANAPOLIS -- A class of medications previously linked ... to negatively affect their physical functioning according to ... University Center for Aging Research, the University of ... , In a systemic review of more than ... drugs with anticholinergic properties, they report that these ...
(Date:7/31/2014)... Washington, D.C. July 31, 2014Today the Elizabeth Glaser ... announced a new partnership that will expedite the ... to health facilities in two districts of the ... partnership between EGPAF and Riders for Health will ... laboratory samples and address a critical bottleneck in ...
(Date:7/31/2014)... school researchers hope to drastically increase the number ... trials, a critical step in testing and developing ... a lack of awareness that clinical testing existsless ... in trials of experimental therapies. , As many ... still don,t enroll, according to the study,s investigators, ...
(Date:7/31/2014)... Controlled application of vacuum pressure is a promising ... (TBI), suggests an experimental study in the August issue ... the Congress of Neurological Surgeons . The journal ... a part of Wolters Kluwer Health . ... the injured area of the brainshows promise as a ...
(Date:7/31/2014)... New Delhi, India (PRWEB) July 31, 2014 ... company, has launched a new service named ‘Remove Bad ... against which bad reviews are published on various review ... study about the world of internet marketing, the sites ... by its competitors in order to tailor the service. ...
Breaking Medicine News(10 mins):Health News:Common drugs adversely impair older adults' physical as well as cognitive functioning 2Health News:Elizabeth Glaser Pediatric AIDS Foundation partners with Riders for Health in Malawi 2Health News:$1.6 million NCI grant to CWRU trains nurses to increase participation in clinical trials 2Health News:$1.6 million NCI grant to CWRU trains nurses to increase participation in clinical trials 3Health News:Vacuum treatment may limit damage after traumatic brain injury 2Health News:Reputation Management India Launches a New Service Called ‘Remove Bad Reviews’ 2
... ... defined, animal-protein free maintenance medium for human embryonic and induced pluripotent stem cells. ... Vancouver, BC (PRWEB) ... the release of TeSR™2 , a defined, animal-protein free maintenance medium for human ...
... CARMEL, Ind., Oct. 13 Conseco, Inc. (NYSE: CNO ... to ensure that all investors have equal access to information, ... 5:30 p.m. on Tuesday, October 13, 2009. The materials ... exhibits that Conseco will submit to the Securities Exchange Commission ...
... Porpoise Evans, a litigation associate in the Miami office of ... among the "40 Under 40" outstanding lawyers of Miami-Dade County ... be honored at the CFF benefit dinner on November 20, ... as one of Miami-Dade County,s top up-and-coming young lawyers is ...
... WASHINGTON, Oct. 13 America,s Health Insurance Plans (AHIP) ... today on passage of health care reform legislation in ... bipartisan health care reform that covers all Americans, improves ... affordable, sustainable path. Health plans have proposed guaranteed ...
... the following statement today from Executive Vice President ... approval today of historic health care reform legislation ... coordinated health benefits and quality focused coverage as ... chronically-ill and underserved Medicare recipients." , ...
... more pre-term infants survive, doctors see more babies with ... News) -- Increased survival of extremely pre-term infants has ... problems caused by abnormal development of blood vessels in ... looked at data on 506 extremely pre-term infants (born ...
Cached Medicine News:Health News:STEMCELL Technologies Inc. Announces Release of Defined, Animal-Protein Free Maintenance Medium for hESCs and hiPSCs 2Health News:Conseco Announces Availability of Important Information on its Website 2Health News:Cystic Fibrosis Foundation Names Greenberg Traurig Attorney D. Porpoise Evans Among the '40 Under 40' Outstanding Lawyers of Miami-Dade County 2Health News:AHIP Statement on Passage of Senate Finance Committee Legislation 2Health News:XLHealth Applauds Quality Focused Reforms in Senate Finance Committee Legislation 2Health News:Eye Problems Increasing in Preemies 2
The Columbus microplate strip washer is for individual strips or whole plates.Programming and control are via an alphanumeric display. Up to 30 methods are stored for easy recall....
... 96PW washes all 96 wells ... automatically. Separate wash and aspiration ... excellent washing ability. Pre-programmed automatic ... removable 96-channel head reduce maintenance ...
Easy to use , Allow for a flexible washing , Uniform and efficient , Very robust and reliable , Adjustable to all well shapes , Rack included (not autoclavable) , Autoclavable at 121C , No e...
... SkanWasher 300 with a ... Vacuum pressure and aspiration ... are adjustable. On-board software ... 8 different programs. External ...
Medicine Products: